In syngeneic mouse tumor models, PDI-1 inhibited the growth of hPD-L1-expressing melanoma and NSCLC by increasing the abundance of effector CD8+ T cells and decreasing that of inhibitory FoxP3 CD4+ Tregs. Here, CD8A is linked to melanoma.